カテゴリー： GlobalInfoResearch, 世界

免疫腫瘍学アッセイの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Immuno Oncology Assays Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101377）・商品コード：GIR9101377
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月11日（※2024年版があります。お問い合わせください）
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、免疫腫瘍学アッセイの世界市場について調べ、まとめました。種類別セグメントは、イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング等、用途別セグメントは、研究、臨床診断等に区分しました。免疫腫瘍学アッセイの世界市場概観、企業動向、企業別免疫腫瘍学アッセイシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・免疫腫瘍学アッセイの市場概観
・免疫腫瘍学アッセイの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・免疫腫瘍学アッセイの企業別販売動向、市場シェア、市場集中度、競争動向
・免疫腫瘍学アッセイの世界市場規模
・免疫腫瘍学アッセイの北米市場分析（アメリカ、カナダ、メキシコ等）
・免疫腫瘍学アッセイのアメリカ市場規模推移
・免疫腫瘍学アッセイのカナダ市場規模推移
・免疫腫瘍学アッセイのメキシコ市場規模推移
・免疫腫瘍学アッセイのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・免疫腫瘍学アッセイのドイツ市場規模推移
・免疫腫瘍学アッセイのイギリス市場規模推移
・免疫腫瘍学アッセイのロシア市場規模推移
・免疫腫瘍学アッセイのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・免疫腫瘍学アッセイの日本市場規模推移
・免疫腫瘍学アッセイの中国市場規模推移
・免疫腫瘍学アッセイの韓国市場規模推移
・免疫腫瘍学アッセイのインド市場規模推移
・免疫腫瘍学アッセイの東南アジア市場規模推移
・免疫腫瘍学アッセイの南米市場分析（ブラジル、アルゼンチン等）
・免疫腫瘍学アッセイの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・免疫腫瘍学アッセイの種類別分析/販売量、売上、市場シェア（イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング）
・免疫腫瘍学アッセイの用途別分析/市場規模（研究、臨床診断）
・免疫腫瘍学アッセイの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・免疫腫瘍学アッセイの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).

Scope of the Report:
The global Immuno Oncology Assays market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Immuno Oncology Assays.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Immuno Oncology Assays market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Immuno Oncology Assays market by product type and applications/end industries.

Market Segment by Companies, this report covers
Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing

Market Segment by Applications, can be divided into
Research
Clinical Diagnostics

【レポートの目次】

Table of Contents

1 Immuno Oncology Assays Market Overview
1.1 Product Overview and Scope of Immuno Oncology Assays
1.2 Classification of Immuno Oncology Assays by Types
1.2.1 Global Immuno Oncology Assays Revenue Comparison by Types (2019-2024)
1.2.2 Global Immuno Oncology Assays Revenue Market Share by Types in 2018
1.2.3 Immunoassay
1.2.4 Flow Cytometry
1.2.5 PCR
1.2.6 Next Generation Sequencing
1.3 Global Immuno Oncology Assays Market by Application
1.3.1 Global Immuno Oncology Assays Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Research
1.3.3 Clinical Diagnostics
1.4 Global Immuno Oncology Assays Market by Regions
1.4.1 Global Immuno Oncology Assays Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Immuno Oncology Assays Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Immuno Oncology Assays Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immuno Oncology Assays Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Immuno Oncology Assays Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immuno Oncology Assays Status and Prospect (2014-2024)
1.5 Global Market Size of Immuno Oncology Assays (2014-2024)
2 Manufacturers Profiles
2.1 Thermo Fischer Scientific
2.1.1 Business Overview
2.1.2 Immuno Oncology Assays Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fischer Scientific Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche Diagnostics
2.2.1 Business Overview
2.2.2 Immuno Oncology Assays Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Diagnostics Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
2.3 Agilent Technologies
2.3.1 Business Overview
2.3.2 Immuno Oncology Assays Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Agilent Technologies Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
2.4 Illumina
2.4.1 Business Overview
2.4.2 Immuno Oncology Assays Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Illumina Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
3 Global Immuno Oncology Assays Market Competition, by Players
3.1 Global Immuno Oncology Assays Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Immuno Oncology Assays Players Market Share
3.2.2 Top 10 Immuno Oncology Assays Players Market Share
3.3 Market Competition Trend
4 Global Immuno Oncology Assays Market Size by Regions
4.1 Global Immuno Oncology Assays Revenue and Market Share by Regions
4.2 North America Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
4.3 Europe Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
4.5 South America Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
5 North America Immuno Oncology Assays Revenue by Countries
5.1 North America Immuno Oncology Assays Revenue by Countries (2014-2019)
5.2 USA Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
5.3 Canada Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
5.4 Mexico Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
6 Europe Immuno Oncology Assays Revenue by Countries
6.1 Europe Immuno Oncology Assays Revenue by Countries (2014-2019)
6.2 Germany Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
6.3 UK Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
6.4 France Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
6.5 Russia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
6.6 Italy Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Immuno Oncology Assays Revenue by Countries
7.1 Asia-Pacific Immuno Oncology Assays Revenue by Countries (2014-2019)
7.2 China Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
7.3 Japan Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
7.4 Korea Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
7.5 India Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
8 South America Immuno Oncology Assays Revenue by Countries
8.1 South America Immuno Oncology Assays Revenue by Countries (2014-2019)
8.2 Brazil Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
8.3 Argentina Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
8.4 Colombia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Immuno Oncology Assays by Countries
9.1 Middle East and Africa Immuno Oncology Assays Revenue by Countries (2014-2019)
9.2 Saudi Arabia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
9.3 UAE Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
9.4 Egypt Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
9.5 Nigeria Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
9.6 South Africa Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
10 Global Immuno Oncology Assays Market Segment by Type
10.1 Global Immuno Oncology Assays Revenue and Market Share by Type (2014-2019)
10.2 Global Immuno Oncology Assays Market Forecast by Type (2019-2024)
10.3 Immunoassay Revenue Growth Rate (2014-2024)
10.4 Flow Cytometry Revenue Growth Rate (2014-2024)
10.5 PCR Revenue Growth Rate (2014-2024)
10.6 Next Generation Sequencing Revenue Growth Rate (2014-2024)
11 Global Immuno Oncology Assays Market Segment by Application
11.1 Global Immuno Oncology Assays Revenue Market Share by Application (2014-2019)
11.2 Immuno Oncology Assays Market Forecast by Application (2019-2024)
11.3 Research Revenue Growth (2014-2019)
11.4 Clinical Diagnostics Revenue Growth (2014-2019)
12 Global Immuno Oncology Assays Market Size Forecast (2019-2024)
12.1 Global Immuno Oncology Assays Market Size Forecast (2019-2024)
12.2 Global Immuno Oncology Assays Market Forecast by Regions (2019-2024)
12.3 North America Immuno Oncology Assays Revenue Market Forecast (2019-2024)
12.4 Europe Immuno Oncology Assays Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Immuno Oncology Assays Revenue Market Forecast (2019-2024)
12.6 South America Immuno Oncology Assays Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Immuno Oncology Assays Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Immuno Oncology Assays Picture
Table Product Specifications of Immuno Oncology Assays
Table Global Immuno Oncology Assays and Revenue (Million USD) Market Split by Product Type
Figure Global Immuno Oncology Assays Revenue Market Share by Types in 2018
Figure Immunoassay Picture
Figure Flow Cytometry Picture
Figure PCR Picture
Figure Next Generation Sequencing Picture
Table Global Immuno Oncology Assays Revenue (Million USD) by Application (2014-2024)
Figure Immuno Oncology Assays Revenue Market Share by Applications in 2018
Figure Research Picture
Figure Clinical Diagnostics Picture
Table Global Market Immuno Oncology Assays Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Immuno Oncology Assays Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Immuno Oncology Assays Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Immuno Oncology Assays Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Immuno Oncology Assays Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Immuno Oncology Assays Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Immuno Oncology Assays Revenue (Million USD) and Growth Rate (2014-2024)
Table Thermo Fischer Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fischer Scientific Immuno Oncology Assays Type and Applications
Table Thermo Fischer Scientific Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table Roche Diagnostics Immuno Oncology Assays Type and Applications
Table Roche Diagnostics Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Immuno Oncology Assays Type and Applications
Table Agilent Technologies Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
Table Illumina Basic Information, Manufacturing Base and Competitors
Table Illumina Immuno Oncology Assays Type and Applications
Table Illumina Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
Table Global Immuno Oncology Assays Revenue (Million USD) by Players (2014-2019)
Table Global Immuno Oncology Assays Revenue Share by Players (2014-2019)
Figure Global Immuno Oncology Assays Revenue Share by Players in 2017
Figure Global Immuno Oncology Assays Revenue Share by Players in 2018
Figure Global Top 5 Players Immuno Oncology Assays Revenue Market Share in 2018
Figure Global Top 10 Players Immuno Oncology Assays Revenue Market Share in 2018
Figure Global Immuno Oncology Assays Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Immuno Oncology Assays Revenue (Million USD) by Regions (2014-2019)
Table Global Immuno Oncology Assays Revenue Market Share by Regions (2014-2019)
Figure Global Immuno Oncology Assays Revenue Market Share by Regions (2014-2019)
Figure Global Immuno Oncology Assays Revenue Market Share by Regions in 2018
Figure North America Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Europe Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure South America Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Table North America Immuno Oncology Assays Revenue by Countries (2014-2019)
Table North America Immuno Oncology Assays Revenue Market Share by Countries (2014-2019)
Figure North America Immuno Oncology Assays Revenue Market Share by Countries (2014-2019)
Figure North America Immuno Oncology Assays Revenue Market Share by Countries in 2018
Figure USA Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Canada Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Mexico Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Table Europe Immuno Oncology Assays Revenue (Million USD) by Countries (2014-2019)
Figure Europe Immuno Oncology Assays Revenue Market Share by Countries (2014-2019)
Figure Europe Immuno Oncology Assays Revenue Market Share by Countries in 2018
Figure Germany Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure UK Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure France Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Russia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Italy Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Immuno Oncology Assays Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Immuno Oncology Assays Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Immuno Oncology Assays Revenue Market Share by Countries in 2018
Figure China Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Japan Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Korea Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure India Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Table South America Immuno Oncology Assays Revenue by Countries (2014-2019)
Table South America Immuno Oncology Assays Revenue Market Share by Countries (2014-2019)
Figure South America Immuno Oncology Assays Revenue Market Share by Countries (2014-2019)
Figure South America Immuno Oncology Assays Revenue Market Share by Countries in 2018
Figure Brazil Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Argentina Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Colombia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Immuno Oncology Assays Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Immuno Oncology Assays Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Immuno Oncology Assays Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Immuno Oncology Assays Revenue Market Share by Countries in 2018
Figure Saudi Arabia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure UAE Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Egypt Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure Nigeria Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Figure South Africa Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
Table Global Immuno Oncology Assays Revenue (Million USD) by Type (2014-2019)
Table Global Immuno Oncology Assays Revenue Share by Type (2014-2019)
Figure Global Immuno Oncology Assays Revenue Share by Type (2014-2019)
Figure Global Immuno Oncology Assays Revenue Share by Type in 2019
Table Global Immuno Oncology Assays Revenue Forecast by Type (2019-2024)
Figure Global Immuno Oncology Assays Market Share Forecast by Type (2019-2024)
Figure Global Immunoassay Revenue Growth Rate (2014-2019)
Figure Global Flow Cytometry Revenue Growth Rate (2014-2019)
Figure Global PCR Revenue Growth Rate (2014-2019)
Figure Global Next Generation Sequencing Revenue Growth Rate (2014-2019)
Table Global Immuno Oncology Assays Revenue by Application (2014-2019)
Table Global Immuno Oncology Assays Revenue Share by Application (2014-2019)
Figure Global Immuno Oncology Assays Revenue Share by Application (2014-2019)
Figure Global Immuno Oncology Assays Revenue Share by Application in 2019
Table Global Immuno Oncology Assays Revenue Forecast by Application (2019-2024)
Figure Global Immuno Oncology Assays Market Share Forecast by Application (2019-2024)
Figure Global Research Revenue Growth Rate (2014-2019)
Figure Global Clinical Diagnostics Revenue Growth Rate (2014-2019)
Figure Global Immuno Oncology Assays Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Immuno Oncology Assays Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Immuno Oncology Assays Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Immuno Oncology Assays Revenue Market Forecast (2019-2024)
Figure Europe Immuno Oncology Assays Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Immuno Oncology Assays Revenue Market Forecast (2019-2024)
Figure South America Immuno Oncology Assays Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Immuno Oncology Assays Revenue Market Forecast (2019-2024)


【掲載企業】

Thermo Fischer Scientific、Roche Diagnostics、Agilent Technologies、Illumina、

★調査レポート[免疫腫瘍学アッセイの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101377)販売に関する免責事項を必ずご確認ください。
★調査レポート[免疫腫瘍学アッセイの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 腫瘍学における遺伝子治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100702 / GlobalInfoResearch / 2019年9月5日 / 本調査レポートは、腫瘍学における遺伝子治療の世界市場について調べ、まとめました。種類別セグメントは、生体外、生体内等、用途別セグメントは、病院、診断センター、研究所等に区分しました。腫瘍学における遺伝子治療の世界市場概観、企業動向、企業別腫瘍学における遺伝子治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・腫瘍学における遺伝子治療の市場概観 ・腫瘍学における遺伝子治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腫瘍学における遺伝子治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・腫瘍学における遺伝子治療の世界市場規模 ・腫瘍学における遺伝子治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・腫瘍学における遺伝子治療のアメリカ市場規模推移 ・腫瘍学における遺伝子治療のカナダ市場規模推移 ・腫瘍学における遺伝子治療のメキシコ市場規模推移 ・腫瘍学における遺伝子治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.  Scope of the Report: The global Gene Therapy in Oncology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot...
  • 腫瘍学小分子薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100188 / GlobalInfoResearch / 2019年10月10日 / 本調査レポートは、腫瘍学小分子薬の世界市場について調べ、まとめました。種類別セグメントは、化学療法薬、免疫調節薬、標的療法薬、ホルモン療法、その他等、用途別セグメントは、血液がん、乳がん、胃腸がん、前立腺がん、肺がん、その他等に区分しました。腫瘍学小分子薬の世界市場概観、企業動向、企業別腫瘍学小分子薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・腫瘍学小分子薬の市場概観 ・腫瘍学小分子薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腫瘍学小分子薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・腫瘍学小分子薬の世界市場規模 ・腫瘍学小分子薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・腫瘍学小分子薬のアメリカ市場規模推移 ・腫瘍学小分子薬のカナダ市場規模推移 ・腫瘍学小分子薬のメキシコ市場規模推移 ・腫瘍学小分子薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Oncology Small Molecule Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncology Small Molecule Drugs. Europe also play important...
  • マイクロアレイおよびラボオンチップの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102033 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、マイクロアレイおよびラボオンチップの世界市場について調べ、まとめました。種類別セグメントは、DNAマイクロアレイ、ラボオンチップ /マイクロフルイディクス等、用途別セグメントは、ゲノミクス、プロテオミクス、細胞アッセイ等に区分しました。マイクロアレイおよびラボオンチップの世界市場概観、企業動向、企業別マイクロアレイおよびラボオンチップシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・マイクロアレイおよびラボオンチップの市場概観 ・マイクロアレイおよびラボオンチップの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・マイクロアレイおよびラボオンチップの企業別販売動向、市場シェア、市場集中度、競争動向 ・マイクロアレイおよびラボオンチップの世界市場規模 ・マイクロアレイおよびラボオンチップの北米市場分析（アメリカ、カナダ、メキシコ等） ・マイクロアレイおよびラボオンチップのアメリカ市場規模推移 ・マイクロアレイおよびラボオンチップのカナダ市場規模推移 ・マイクロアレイおよびラボオンチップのメキシコ市場規模推移...A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time, to achieve higher throughput and speed. Typically, a biochip's surface area is no larger than a fingernail. Like a computer chip, that can perform millions of mathematical operations in one-second, a biochip can perform thousands of biological reactions, such as decoding genes, in a few seconds. Scope of the Report: Microarrays (biochips) has been the technology of choice for large-scale studies of gene expression since their invention in the 1990s. Although microarray technology continues...

    • ◆H&Iグローバルリサーチのお客様（例）◆